SPECTRAL MEDICAL INC (EDT.CA) Fundamental Analysis & Valuation

TSX:EDT • CA8475771033

Current stock price

1.43 CAD
0 (0%)
Last:

This EDT.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EDT.CA Profitability Analysis

1.1 Basic Checks

  • EDT had negative earnings in the past year.
  • In the past year EDT has reported a negative cash flow from operations.
  • In the past 5 years EDT always reported negative net income.
  • EDT had a negative operating cash flow in each of the past 5 years.
EDT.CA Yearly Net Income VS EBIT VS OCF VS FCFEDT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • EDT has a Return On Assets of -513.23%. This is in the lower half of the industry: EDT underperforms 73.91% of its industry peers.
Industry RankSector Rank
ROA -513.23%
ROE N/A
ROIC N/A
ROA(3y)-227.94%
ROA(5y)-174.27%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EDT.CA Yearly ROA, ROE, ROICEDT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

  • EDT has a better Gross Margin (56.16%) than 91.30% of its industry peers.
  • In the last couple of years the Gross Margin of EDT has declined.
  • The Profit Margin and Operating Margin are not available for EDT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.21%
GM growth 5Y-10.46%
EDT.CA Yearly Profit, Operating, Gross MarginsEDT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. EDT.CA Health Analysis

2.1 Basic Checks

  • EDT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for EDT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EDT.CA Yearly Shares OutstandingEDT.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EDT.CA Yearly Total Debt VS Total AssetsEDT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

  • Based on the Altman-Z score of -39.80, we must say that EDT is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -39.80, EDT is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -39.8
ROIC/WACCN/A
WACC8.3%
EDT.CA Yearly LT Debt VS Equity VS FCFEDT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

2.3 Liquidity

  • EDT has a Current Ratio of 0.11. This is a bad value and indicates that EDT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.11, EDT is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
  • EDT has a Quick Ratio of 0.11. This is a bad value and indicates that EDT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • EDT has a worse Quick ratio (0.10) than 65.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.1
EDT.CA Yearly Current Assets VS Current LiabilitesEDT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EDT.CA Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.06%

3.2 Future

  • EDT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.80% yearly.
  • EDT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 143.30% yearly.
EPS Next Y76.02%
EPS Next 2Y41.42%
EPS Next 3Y34.3%
EPS Next 5Y31.8%
Revenue Next Year91.66%
Revenue Next 2Y156.78%
Revenue Next 3Y219.98%
Revenue Next 5Y143.3%

3.3 Evolution

EDT.CA Yearly Revenue VS EstimatesEDT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
EDT.CA Yearly EPS VS EstimatesEDT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 2033 0 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. EDT.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EDT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EDT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EDT.CA Price Earnings VS Forward Price EarningsEDT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDT.CA Per share dataEDT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1 -0.15 -0.2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EDT's earnings are expected to grow with 34.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y34.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EDT.CA Dividend Analysis

5.1 Amount

  • No dividends for EDT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDT.CA Fundamentals: All Metrics, Ratios and Statistics

SPECTRAL MEDICAL INC

TSX:EDT (3/27/2026, 7:00:00 PM)

1.43

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-26
Earnings (Next)05-07
Inst Owners0.1%
Inst Owner ChangeN/A
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap418.36M
Revenue(TTM)N/A
Net Income(TTM)-41.70M
Analysts83.33
Price Target3.16 (120.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-21.43%
EPS NY rev (3m)-183.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-45.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)45.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 154.66
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.01
BVpS-0.23
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -513.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.16%
FCFM N/A
ROA(3y)-227.94%
ROA(5y)-174.27%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.21%
GM growth 5Y-10.46%
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 78.54%
Cap/Sales 7.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.1
Altman-Z -39.8
F-Score3
WACC8.3%
ROIC/WACCN/A
Cap/Depr(3y)35.44%
Cap/Depr(5y)73.91%
Cap/Sales(3y)4.85%
Cap/Sales(5y)10.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y76.02%
EPS Next 2Y41.42%
EPS Next 3Y34.3%
EPS Next 5Y31.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-42.06%
Revenue Next Year91.66%
Revenue Next 2Y156.78%
Revenue Next 3Y219.98%
Revenue Next 5Y143.3%
EBIT growth 1Y50.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.79%
OCF growth 3YN/A
OCF growth 5YN/A

SPECTRAL MEDICAL INC / EDT.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPECTRAL MEDICAL INC (EDT.CA) stock?

ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA.


What is the valuation status for EDT stock?

ChartMill assigns a valuation rating of 1 / 10 to SPECTRAL MEDICAL INC (EDT.CA). This can be considered as Overvalued.


What is the profitability of EDT stock?

SPECTRAL MEDICAL INC (EDT.CA) has a profitability rating of 1 / 10.